Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Almonty Industries announces 1-for-1.5 share consolidation (SeekingAlpha) +++ ALMONTY Aktie +3,56%

IMPLANTICA Aktie

 >IMPLANTICA Aktienkurs 
4.035 EUR    +4.7%    (Tradegate)
Ask: 4.15 EUR / 490 Stück
Bid: 4.095 EUR / 490 Stück
Tagesumsatz: 100 Stück
Realtime Kurs von 8 bis 22 Uhr!
IMPLANTICA Aktie über LYNX handeln
>IMPLANTICA Performance
1 Woche: -1,0%
1 Monat: +7,3%
3 Monate: +46,1%
6 Monate: +30,2%
1 Jahr: +14,4%
laufendes Jahr: +28,9%
>IMPLANTICA Aktie
Name:  IMPLANTICA AG SDR./1
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0014855029 / A2QCUH
Symbol/ Ticker:  8IM1 (Frankfurt)
Kürzel:  FRA:8IM1, ETR:8IM1, 8IM1:GR
Index:  -
Webseite:  https://www.implantica.co..
Marktkapitalisierung:  -
Umsatz:  2.08 Mio. EUR
EBITDA:  -22.48 Mio. EUR
Gewinn je Aktie:  -0.064 EUR
Schulden:  0.516 Mio. EUR
Liquide Mittel:  60.28 Mio. EUR
Umsatz-/ Gewinnwachstum:  25% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / - / -
Gewinnm./ Eigenkapitalr.:  - / -21.52%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  IMPLANTICA
Letzte Datenerhebung:  03.07.25
>IMPLANTICA Eigentümer
Aktien: -
f.h. Aktien: 8.31 Mio. St.
Insider Eigner: -
Instit. Eigner: 13.23%
Leerverk. Aktien: -
>IMPLANTICA Peer Group

 
01.07.25 - 08:21
Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success (PR Newswire)
 
VADUZ, Liechtenstein, July 1, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of treatment for acid reflux with its unique device RefluxStop®, a treatment field with 1 billion sufferers, announces the publication of RefluxStop's extraordinary 5-year clinical......
24.06.25 - 08:18
Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop® for US market approval (PR Newswire)
 
VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
17.06.25 - 08:21
Implantica announces successful UK RefluxStop™ Users Meeting addressing growing demand after the final and positive UK NICE recommendations on use of RefluxStop in NHS public hospitals (PR Newswire)
 
VADUZ, Liechtenstein, June 17, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of treatment for acid reflux with its unique device RefluxStop™, a treatment field with 1 billion sufferers, announces the successful first UK National Users Meeting bringing......
12.06.25 - 08:36
Implantica announces new real-world Swiss study on 99 RefluxStop™ patients comparing small and large hiatal hernia, confirming equally excellent long-term results (PR Newswire)
 
VADUZ, Liechtenstein, June 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
04.06.25 - 08:15
Implantica announces that UK NICE has published positive recommendations for the RefluxStop™ procedure in the NHS public hospitals (PR Newswire)
 
VADUZ, Liechtenstein, June 4, 2025 /PRNewswire/ -- Implantica AG (publ.), providing the unique device RefluxStop™ for the treatment of acid reflux, announces that the world-renowned National Institute for Healthcare Excellence (NICE) payer advisory agency for NHS public hospitals in the......
27.05.25 - 08:21
Implantica′s RefluxStop™ stimulates intensive dialogue at DDW, the world′s largest Digestive Disease conference, held in the U.S. (PR Newswire)
 
VADUZ, Liechtenstein, May 27, 2025 /PRNewswire/ -- Implantica AG (publ.) reports successful pre-launch activities in the U.S., pending FDA approval, with European real-world clinical evidence generating much interest from U.S. surgeons. Several presentations on RefuxStop™ were held at......
15.05.25 - 20:54
Bulletin from the Annual General Meeting of Implantica AG (PR Newswire)
 
VADUZ, Liechtenstein, May 15, 2025 /PRNewswire/ -- Today, May 15, 2025, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution proposals. A summary of the......
09.05.25 - 08:33
Implantica publishes Interim Report January - March 2025 (Q1) (PR Newswire)
 
VADUZ, Liechtenstein, May 9, 2025 /PRNewswire/ -- Global expansion of RefluxStop™ Significant events in the first quarter of 2025 Received positive feedback from U.S. FDA on our Clinical Module 2 Premarket Approval (PMA) application. FDA accepted Module 1 containing the quality systems......
09.05.25 - 08:01
Implantica publishes Interim Report January – March 2025 (Q1) (Cision)
 
Global expansion of RefluxStop™ Significant events in the first quarter of 2025 · Received positive feedback from U.S. FDA on our Clinical Module 2 Premarket Approval (PMA) application. FDA accepted Module 1 containing the quality systems and manufacturing information for RefluxStop™, and this module is now considered closed · Results from the largest real-world RefluxStop™ study published, involving 79 patients for up to 17 months follow-up in Germany showing median improvement in quality of life questionnaire, GERD-HRQL of 100% · World-leading and largest hospital in Spain, La...
06.05.25 - 08:24
Implantica announces 15th RefluxStop™ Center in Spain (PR Newswire)
 
VADUZ, Liechtenstein, May 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
06.05.25 - 08:06
Implantica announces 15[th] RefluxStop™ Center in Spain (Cision)
 
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces another prestigious Center of Excellence in Spain to offer RefluxStop™, Hospital Universitario Central de Asturias in Oviedo, Spain. Congratulations to esteemed surgeon, Dra. Maria Moreno Gijón who performed the first RefluxStop™ procedures at Hospital Universitario Central de Asturias recently. As the principal healthcare center in the Asturias region of...
02.05.25 - 13:51
Implantica presents the first quarter 2025 on May 9 at 15:00 CEST (PR Newswire)
 
VADUZ, Liechtenstein, May 2, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2025 at 15:00 CEST on May 9. The interim report for the first quarter will be published at 8:00 a.m. CEST on the same day. The presentation will be in English......
25.04.25 - 10:45
Notice of Annual General Meeting of Implantica AG (PR Newswire)
 
VADUZ, Liechtenstein, April 25, 2025 /PRNewswire/ -- The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Thursday, May 15, 2025, at 14:00 at Hotel Kommod, Industriering 14, 9491 Ruggell,......
23.04.25 - 08:18
Implantica opens a new RefluxStop™ center in a new region of Spain, addressing the fast-growing demand (PR Newswire)
 
VADUZ, Liechtenstein, April 23, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
15.04.25 - 08:33
Implantica publishes Annual Report 2024 (PR Newswire)
 
VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2024. The annual report is now available on the company's website. "Today, we......
15.04.25 - 08:06
Implantica publishes Annual Report 2024 (Cision)
 
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2024. The annual report is now available on the company's website. “Today, we are proud to report that RefluxStop™ has achieved a crucial milestone in transforming the lives of now more than 1'200 patients treated by 45 world-leading European Anti-Reflux Surgeons at top reflux centers from Germany, Switzerland, UK, Italy, Spain, Austria, Norway, and Sweden, and an additional very interested 100+ surgeons from the U.S. eagerly waiting to...
10.04.25 - 08:15
Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results (PR Newswire)
 
VADUZ, Liechtenstein, April 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
25.03.25 - 08:39
Implantica′s RefluxStop™ garners strong interest at SAGES (PR Newswire)
 
VADUZ, Liechtenstein, March 25, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
19.03.25 - 08:45
Implantica announces further expansion of RefluxStop™ centers of excellence and patient access in Spain (PR Newswire)
 
VADUZ, Liechtenstein, March 19, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
09.01.25 - 09:01
Implantica announces new exceptional published data from the largest real-world study from Germany (PR Newswire)
 
VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der guckt die Bälle weg. - Fritz Walter
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!